Characterization of Chemoresistant Cell Populations Improves Risk Stratification and Therapy Prediction in Pediatric AML
Mohammad Javad Najaf Panah, Alexandra McLean Stevens, Michael Krueger, Max P Rochette, Sohani K Sandhu, Lana E Kim, Hua‐Sheng Chiu, Jessica L. Epps, Sonal Somvanshi, Barry Zorman, María Rodríguez Martínez, Marianna Rapsomaniki, Susanne Unger, Burkhard Becher, Joanna S. Yi, , Pavel Sumazin
The paper identifies chemoresistant cell populations in pediatric AML that improve risk prediction and reveal therapeutic targets for high-risk patients.
bioRxiv · Sep 25, 2025 · PreprintCancer Biology